Peter Jüni

284.4k total citations · 28 hit papers
423 papers, 65.4k citations indexed

About

Peter Jüni is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Jüni has authored 423 papers receiving a total of 65.4k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Surgery, 179 papers in Cardiology and Cardiovascular Medicine and 56 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Jüni's work include Coronary Interventions and Diagnostics (129 papers), Cardiac Valve Diseases and Treatments (73 papers) and Antiplatelet Therapy and Cardiovascular Diseases (62 papers). Peter Jüni is often cited by papers focused on Coronary Interventions and Diagnostics (129 papers), Cardiac Valve Diseases and Treatments (73 papers) and Antiplatelet Therapy and Cardiovascular Diseases (62 papers). Peter Jüni collaborates with scholars based in Switzerland, Canada and United Kingdom. Peter Jüni's co-authors include Jonathan A C Sterne, Kenneth F. Schulz, David Moher, Doug Altman, Jelena Savović, Julian P. T. Higgins, Peter C Gøtzsche, Laura Weeks, Andrew D Oxman and Matthias Egger and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter Jüni

414 papers receiving 63.7k citations

Hit Papers

The Cochrane Collaboration's tool for assessing ... 1999 2026 2008 2017 2011 2001 2008 1999 2007 5.0k 10.0k 15.0k 20.0k 25.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    2011 26.4k citations Julian P. T. Higgins, Doug Altman et al. BMJ profile →
  2. Assessing the quality of controlled clinical trials
    2001 2.4k citations Peter Jüni et al. BMJ profile →
  3. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    2008 1.9k citations Lesley Wood, Matthias Egger et al. BMJ profile →
  4. The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
    1999 1.6k citations Peter Jüni profile →
  5. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
    2007 1.3k citations Peter Wenaweser, Peter Jüni et al. profile →
  6. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
    2003 980 citations Matthias Egger, Peter Jüni et al. profile →
  7. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
    2011 827 citations Stephan Reichenbach, Matthias Egger et al. BMJ profile →
  8. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
    2012 768 citations Jelena Savović, Douglas G. Altman et al. profile →
  9. Direction and impact of language bias in meta-analyses of controlled trials: empirical study
    2002 682 citations Peter Jüni, Jonathan A C Sterne et al. profile →
  10. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
    2004 609 citations Peter Jüni, Stephan Reichenbach et al. profile →
  11. Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
    2013 578 citations Stephan Windecker, Peter Jüni et al. profile →
  12. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study
    2011 527 citations Paul Dieppe, Stephan Reichenbach et al. BMJ profile →
  13. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    2012 519 citations Jelena Savović, Peter Jüni et al. profile →
  14. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
    2010 461 citations Stephan Reichenbach, Doug Altman et al. BMJ profile →
  15. Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVR
    2014 457 citations George C.M. Siontis, Peter Jüni et al. profile →
  16. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    2008 453 citations Stephan Windecker, Patrick W. Serruys et al. profile →
  17. Viscosupplementation for Osteoarthritis of the Knee
    2012 444 citations Peter Jüni, Bruno R. da Costa et al. profile →
  18. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
    2010 396 citations Peter Jüni, Stephan Reichenbach et al. BMJ profile →
  19. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
    2019 386 citations Subodh Verma, C. David Mazer et al. profile →
  20. Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis
    2013 385 citations Peter Jüni et al. profile →
  21. Intra-articular corticosteroid for knee osteoarthritis
    2015 361 citations Peter Jüni, Stephan Reichenbach et al. profile →
  22. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease
    2016 305 citations Peter Jüni, Bruno R. da Costa et al. profile →
  23. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
    2018 300 citations Philippe Kolh, Peter Jüni et al. European Heart Journal profile →
  24. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial
    2018 294 citations Peter Jüni et al. profile →
  25. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis
    2019 259 citations George C.M. Siontis, Fabien Praz et al. European Heart Journal profile →
  26. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis
    2021 220 citations Bruno R. da Costa, Tiago Pereira et al. BMJ profile →
  27. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
    2022 171 citations Fabien Praz, Davide Capodanno et al. profile →
  28. Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
    2025 40 citations Peter Jüni, Dik Heg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jüni Switzerland 99 20.9k 16.6k 9.6k 8.1k 5.7k 423 65.4k
George A. Wells Canada 126 18.1k 0.9× 14.3k 0.9× 7.7k 0.8× 9.4k 1.2× 6.6k 1.2× 875 89.9k
Jonathan J Deeks United Kingdom 92 20.0k 1.0× 9.1k 0.5× 11.8k 1.2× 16.8k 2.1× 3.8k 0.7× 368 96.6k
Simon G. Thompson United Kingdom 78 16.4k 0.8× 14.7k 0.9× 14.5k 1.5× 13.1k 1.6× 3.2k 0.6× 223 90.9k
Erik von Elm Switzerland 43 18.6k 0.9× 9.3k 0.6× 10.4k 1.1× 13.1k 1.6× 3.7k 0.6× 131 89.7k
Christopher H. Schmid United States 88 10.1k 0.5× 10.4k 0.6× 7.3k 0.8× 8.3k 1.0× 3.3k 0.6× 404 63.2k
M. Hassan Murad United States 146 24.1k 1.2× 9.5k 0.6× 16.2k 1.7× 17.0k 2.1× 4.1k 0.7× 978 103.8k
Jonathan A C Sterne United Kingdom 97 13.3k 0.6× 7.6k 0.5× 8.7k 0.9× 12.0k 1.5× 3.7k 0.6× 402 84.3k
Doug Altman United Kingdom 43 12.8k 0.6× 6.4k 0.4× 7.4k 0.8× 7.3k 0.9× 3.4k 0.6× 93 64.7k
Jan P. Vandenbroucke Netherlands 93 21.8k 1.0× 13.2k 0.8× 12.6k 1.3× 15.5k 1.9× 4.2k 0.7× 439 111.3k
Andrew D Oxman Norway 93 18.6k 0.9× 9.1k 0.5× 11.7k 1.2× 12.3k 1.5× 6.1k 1.1× 300 107.1k

Countries citing papers authored by Peter Jüni

Since Specialization
Citations

This map shows the geographic impact of Peter Jüni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jüni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jüni more than expected).

Fields of papers citing papers by Peter Jüni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jüni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jüni. The network helps show where Peter Jüni may publish in the future.

Co-authorship network of co-authors of Peter Jüni

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jüni. A scholar is included among the top collaborators of Peter Jüni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jüni. Peter Jüni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buccheri, Sergio, Stefan James, Marion Mafham, et al.. (2025). Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience. Trials. 26(1). 24–24. 1 indexed citations
2.
Jüni, Peter, Sotiris Antoniou, Elena Arbelo, et al.. (2025). 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention. European Heart Journal. 46(20). 1885–1894. 7 indexed citations
3.
Angelantonio, Emanuele Di, Lisa Pennells, Magdy Abdelhamid, et al.. (2025). 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models. European Heart Journal. 46(20). 1895–1906. 2 indexed citations
4.
Mahendiran, Thabo, Frédéric Bouisset, Pim A.L. Tonino, et al.. (2025). Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis. European Heart Journal. 46(22). 2092–2100.
5.
Ghani, Maryam, Brett W. C. Kennedy, Alex Pitcher, et al.. (2024). The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 26(7). 2706–2721. 14 indexed citations
6.
Odutayo, Ayodele, Bruno R. da Costa, Tiago Pereira, et al.. (2021). Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression. Journal of the American Heart Association. 10(18). e019918–e019918. 18 indexed citations
7.
Lauder, Lucas, Bruno R. da Costa, Sebastian Ewen, et al.. (2020). Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis. European Heart Journal. 41(27). 2556–2569. 10 indexed citations
8.
Fournier, Stéphane, Carlos Collet, Panagiotis Xaplanteris, et al.. (2020). Global Fractional Flow Reserve Value Predicts 5‐Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia. Journal of the American Heart Association. 9(24). e017729–e017729. 7 indexed citations
9.
Jung, James J., Peter Jüni, Gerald Lebovic, & Teodor Grantcharov. (2018). First-year Analysis of the Operating Room Black Box Study. Annals of Surgery. 271(1). 122–127. 126 indexed citations
10.
Jung, James J., Cornelia M. Borkhoff, Peter Jüni, & Teodor Grantcharov. (2018). Non-Technical Skills for Surgeons (NOTSS): Critical appraisal of its measurement properties. The American Journal of Surgery. 216(5). 990–997. 37 indexed citations
11.
12.
Piróth, Zsolt, Gábor Tóth, Pim A.L. Tonino, et al.. (2017). Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation. Circulation Cardiovascular Interventions. 10(8). 114 indexed citations
13.
Praz, Fabien, George C.M. Siontis, Subodh Verma, Stephan Windecker, & Peter Jüni. (2017). Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients. Current Opinion in Cardiology. 32(2). 117–122. 10 indexed citations
14.
Valgimigli, Marco, Héctor Bueno, Robert A. Byrne, et al.. (2017). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Kardiologia Polska. 75(12). 1217–1299. 94 indexed citations
15.
Binder, Ronald K., Stefan Stortecky, Dik Heg, et al.. (2015). Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland. Circulation Cardiovascular Interventions. 8(10). 77 indexed citations
16.
Pilgrim, Thomas, Dik Heg, Kali Tal, et al.. (2015). Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction. PLoS ONE. 10(9). e0137047–e0137047. 28 indexed citations
17.
Selby, Kevin, David Nanchen, Reto Auer, et al.. (2015). Low statin use in adults hospitalized with acute coronary syndrome. Preventive Medicine. 77. 131–136. 16 indexed citations
18.
Higgins, Julian P. T., Doug Altman, Peter C Gøtzsche, et al.. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343(oct18 2). d5928–d5928. 26405 indexed citations breakdown →
19.
Wood, Lesley, Matthias Egger, Lise Lotte Gluud, et al.. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 336(7644). 601–605. 1850 indexed citations breakdown →
20.
Jüni, Peter, Stephan Reichenbach, & Paul Dieppe. (2006). Osteoarthritis: rational approach to treating the individual. Best Practice & Research Clinical Rheumatology. 20(4). 721–740. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George A. Wells Breakdown of academic impact, for papers by Jonathan J Deeks Breakdown of academic impact, for papers by Simon G. Thompson Breakdown of academic impact, for papers by Erik von Elm Breakdown of academic impact, for papers by Christopher H. Schmid Breakdown of academic impact, for papers by M. Hassan Murad Breakdown of academic impact, for papers by Jonathan A C Sterne Breakdown of academic impact, for papers by Doug Altman Breakdown of academic impact, for papers by Jan P. Vandenbroucke Breakdown of academic impact, for papers by Andrew D Oxman
Rankless by CCL
2026